Loading...
Loading...
Valeant Pharmaceuticals International, Inc.
VRXVRX today announced that it will host a conference call and a live webcast along with a slide presentation on Monday, October 26, 2015 at 8:00 a.m. ET (5:00 a.m. PT). The purpose of the call will be to lay out the facts including allegations made against our company regarding our relationship with Philidor and R&O, our accounting practices, and channel stuffing that contain numerous errors, unsupported speculation and incorrect interpretations of facts and circumstances to the detriment of the shareholders of the Company.
Participants on the call will include:
Norma Provencio, Board Member, Chairman Audit and Risk Committee
Theo Melas-Kyriazi, Board Member, Member Audit and Risk Committee
Katharine Stevenson, Board Member, Member Audit and Risk Committee
Howard Schiller, Board Member, former Chief Financial Officer
Robert Hale, Board Member, Partner of ValueAct Capital
J. Michael Pearson, Chairman and Chief Executive Officer
Robert Chai-Onn, General Counsel
Robert Rosiello, Chief Financial Officer
Tanya Carro, Corporate Controller
Ari Kellen, Company Group Chairman
"We look forward to our call on Monday where we will address and refute recent allegations," stated J. Michael Pearson, chairman and chief executive officer. stated J. Michael Pearson, chairman
See full press release© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in